Source list

Primary sources include vendor advisories, NVD, CISA KEV, HHS HC3, OCR, FDA, state regulator materials, official company disclosures, and other authoritative public sources. Secondary reporting may be used for context but should not create unsupported claims.

Selection criteria

Visible items should change a decision, deadline, owner, investigation priority, regulatory posture, privacy posture, patient-safety posture, or operational risk. Items that do not change a decision are collapsed, exported, or excluded from the main reading path.

Healthcare Incident Watch

Incident Watch separates verified material items from secondary-source awareness. Verified material items require an official company notice, regulator posting, OCR/HHS breach portal entry, state attorney general notice, court or settlement document, or similarly authoritative source. Secondary reporting can appear for awareness, but it should not trigger breach notification, OCR reporting, or incident-response escalation unless local scope or evidence exists.

Old events are not ranked from article publication date alone. Historical events require a material currentness basis such as a new regulator posting, official notice, affected-count update, settlement, lawsuit, or other verified material update.

Healthcare Relevance Score (HRS)

HRS is a 0-100 operational relevance score used to rank healthcare impact. It is not CVSS severity and does not replace exploitability evidence.

How HRS is calculated: the score combines clinical workflow adjacency, patient data-path exposure, medical-device/OT relevance, vendor concentration/dependency, and identity blast-radius indicators. Each axis is evidence-weighted and normalized into a composite score.

Bands: 0-39 Low, 40-69 Moderate, 70-84 High, 85-100 Critical-healthcare relevance. Higher HRS means the issue is more likely to affect healthcare operations and should be validated against local assets sooner.

Interpretation guardrail: HRS prioritizes operational validation order; exploit status, KEV inclusion, and vendor fixed-release availability remain separate decision inputs.

Confidence model

Source confidence combines evidence type, source quality, corroboration, and specificity. Vendor-confirmed and government-catalog evidence is stronger than analyst inference. Analyst judgment is labeled when a healthcare operational conclusion is inferred from deployment patterns rather than directly stated by a source.

KEV and exploitation-source explanation

CISA KEV, vendor statements, NVD records, credible exploitation catalogs, and public exploit reporting are treated separately. A KEV entry or public exploit can change operational priority, but it does not by itself prove healthcare targeting, clinical compromise, PHI exposure, or breach status.

Clinical and privacy limits

A CVE, KEV listing, or vulnerability disclosure is not a clinical compromise or HIPAA breach finding. Direct clinical impact requires evidence that the affected system is a clinical system, medical device, clinical communication platform, imaging system, medication system, EHR component, or confirmed patient-care dependency.

Medical device and OT coverage limitations

Medical-device and OT coverage is limited to public FDA communications, vendor advisories, CISA ICS advisories, HHS HC3 materials, and clearly bounded telemetry. A single sensor, lab signal, or generic internet scan is not treated as sector-level healthcare OT/IoMT intelligence unless corroborated by material healthcare evidence.

AI-assisted drafting disclosure

Clinical Cyber Dispatch may use AI-assisted drafting, summarization, classification, and formatting. Human review and automated QA gates are used to constrain clinical, privacy, regulatory, attribution, and exploitation claims to evidence-supported language.

Correction process

If a reader identifies an error, stale source, broken link, or unsupported claim, contact ceo.clinicalcyber@proton.me. Corrections may be applied to the current issue, noted in a later issue, or used to update methodology and QA gates.

Limitations

The publication is informational only and is not legal, regulatory, compliance, medical, or incident-response advice. Readers should verify CVE and remediation data against vendor advisories and internal asset data before making operational decisions.